Country

daiichi-sankyo-s-comments-enrages-the-singh-family-the-former-shareholder-and-owners-of-ranbaxy

Daiichi's comments upset former Ranbaxy owners

  • Japan
  • |
  • News

Singapore: Japanese drugmaker Daiichi Sankyo, which currently holds a majority stake in Ranbaxy, had earlier highlighted that it believes that former shareholders of Ranbaxy concealed and misrepresented critical information concerning the... Read more

us-fda-panel-s-opinion-was-somewhat-at-odds-with-the-agency-s-own-scientists-who-issued-a-negative-review-of-the-merck-drug

FDA votes +ve for Merck drug despite glitches in trial...


  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: An US FDA panel has voted that Merck & Co experimental insomnia drug appears to be safe and effective, despite... Read more

good-to-go-3sbio-shareholders-are-in-favor-of-plan-of-merger

3SBio shareholders get nod for merger agreement


  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The shareholders of China-based 3SBio have voted at an extraordinary general meeting (EGM) in favor of a proposal... Read more

merck-received-us-fda-approval-for-liptruzet-ezetimibe-and-atorvastatin-tablets-for-elevated-low-density-lipoprotein-ldl-cholesterol

Merck gets US FDA nod for cholesterol drug

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Merck, also known as MSD outside the US and Canada, received US FDA approval for Liptruzet (ezetimibe and atorvastatin) tablets... Read more

janssen-pharma-a-johnson-johnson-company-recalled-170-batches-of-children-s-dye-free-tylenol-suspension-as-they-contained-a-higher-concentration-of-liver-toxin-acetaminophen

Janssen faces suspension in S Korea, recalls drug

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Janssen Pharma, which is member of the Johnson&Johnson (J&J) group of companies, South Korean unit has been ordered to stop manufacturing... Read more

regeneron-acquires-rights-to-sanofi-s-ophthalmology-antibodies-targeting-the-pdgf-platelet-derived-growth-factor-and-ang2-angiopoietin2

Regeneron acquires Sanofi eye care antibodies

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Regeneron Pharmaceuticals has acquired exclusive rights to two families of novel antibodies from Sanofi. Regeneron acquired... Read more

new-virus-called-novel-coronavirus-ncov-kills-five-people-in-saudi-arabia

New coronavirus kills 5 in Saudi Arabia

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Saudi Arabia Ministry of Health has seven new laboratory confirmed cases of infection dealing with the novel coronavirus (nCoV),... Read more

australia-is-adopting-antiangiogenesis-therapy-and-spectral-domain-optical-coherence-tomography-sd-oct-to-counter-age-related-macular-degeneration-amd

No of AMD patients to reach 1.7 mn by 2030 in Aus

  • Australia
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The number of Australians with age-related macular degeneration (AMD) is expected to grow to over 1.7 million by 2030, yet many... Read more

bristol-myers-squibb-bms-received-us-fda-s-approval-for-its-supplemental-new-drug-application-snda-for-non-nucleoside-reverse-transcriptase-inhibitor-nnrti-sustiva-efavirenz

BMS 'capsule sprinkle' HIV drug gets US FDA nod

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Bristol-Myers Squibb (BMS) received US FDA's approval for a supplemental new drug application (sNDA) for Sustiva (efavirenz),... Read more

illumina-decode-genetics-national-hospital-of-iceland-and-the-university-of-iceland-discover-the-nonsense-mutation-in-lgr4-that-causes-osteoporosis-squamous-cell-carcinoma-of-the-skin-and-biliary-tract-cance

Nonsense mutation causes osteoporosis, cancer

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: deCODE genetics (an Amgen subsidiary) and Illumina, global leaders in analyzing and understanding the human genome, together... Read more

nova-buys-mazor-s-renaissance-surgical-robot

Nova buys Mazor’s Renaissance surgical robot

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

New Delhi: Nova Medical Center, a leading short-stay surgical chain in India, placed an order for a Mazor Robotics' Renaissance surgical... Read more

oramed-unstable-diabetes-drug-is-a-hit

Oramed ‘unstable diabetes’ drug is a hit

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Oramed Pharmaceuticals' article titled, ‘Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X